Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis.

Arend WP, Firestein GS.

Nat Rev Rheumatol. 2012 Oct;8(10):573-86. doi: 10.1038/nrrheum.2012.134. Epub 2012 Aug 21. Review.

PMID:
22907289
2.
3.

Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies that are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis.

Young KA, Deane KD, Derber LA, Hughes-Austin JM, Wagner CA, Sokolove J, Weisman MH, Buckner JH, Mikuls TR, O'Dell JR, Keating RM, Gregersen PK, Robinson WH, Holers VM, Norris JM.

Arthritis Rheum. 2013 Aug;65(8):1995-2004. doi: 10.1002/art.38022.

4.

Cell and cytokine imbalances in rheumatoid synovitis.

Boissier MC.

Joint Bone Spine. 2011 May;78(3):230-4. doi: 10.1016/j.jbspin.2010.08.017. Epub 2010 Oct 18. Review.

PMID:
20961791
5.
6.

Anti-citrullinated protein antibodies promote apoptosis of mature human Saos-2 osteoblasts via cell-surface binding to citrullinated heat shock protein 60.

Lu MC, Yu CL, Yu HC, Huang HB, Koo M, Lai NS.

Immunobiology. 2016 Jan;221(1):76-83. doi: 10.1016/j.imbio.2015.07.019. Epub 2015 Jul 29.

PMID:
26275591
7.

Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis.

de Hair MJ, van de Sande MG, Ramwadhdoebe TH, Hansson M, Landewé R, van der Leij C, Maas M, Serre G, van Schaardenburg D, Klareskog L, Gerlag DM, van Baarsen LG, Tak PP.

Arthritis Rheumatol. 2014 Mar;66(3):513-22. doi: 10.1002/art.38273.

8.

What happens before the onset of rheumatoid arthritis?

Rantapää-Dahlqvist S.

Curr Opin Rheumatol. 2009 May;21(3):272-8. doi: 10.1097/BOR.0b013e32832a2e44. Review.

PMID:
19365265
9.

Anti-citrullinated peptides as autoantigens in rheumatoid arthritis-relevance to treatment.

Sakkas LI, Bogdanos DP, Katsiari C, Platsoucas CD.

Autoimmun Rev. 2014 Nov;13(11):1114-20. doi: 10.1016/j.autrev.2014.08.012. Epub 2014 Aug 23. Review.

PMID:
25182207
10.

Towards a stratified targeted approach with biologic treatments in rheumatoid arthritis: role of synovial pathobiology.

Astorri E, Nerviani A, Bombardieri M, Pitzalis C.

Curr Pharm Des. 2015;21(17):2216-24. Review.

PMID:
25760296
11.

Alterations of the synovial T cell repertoire in anti-citrullinated protein antibody-positive rheumatoid arthritis.

Cantaert T, Brouard S, Thurlings RM, Pallier A, Salinas GF, Braud C, Klarenbeek PL, de Vries N, Zhang Y, Soulillou JP, Tak PP, Baeten D.

Arthritis Rheum. 2009 Jul;60(7):1944-56. doi: 10.1002/art.24635.

12.

Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients.

Barra L, Scinocca M, Saunders S, Bhayana R, Rohekar S, Racapé M, Coles R, Cairns E, Bell DA.

Arthritis Rheum. 2013 Jun;65(6):1439-47. doi: 10.1002/art.37911.

13.

The preclinical stages of RA: lessons from human studies and animal models.

El-Gabalawy H.

Best Pract Res Clin Rheumatol. 2009 Feb;23(1):49-58. doi: 10.1016/j.berh.2008.11.004. Review.

PMID:
19233045
14.

Cartilage oligomeric matrix protein associates differentially with erosions and synovitis and has a different temporal course in cyclic citrullinated peptide antibody (anti-CCP)-positive versus anti-CCP-negative early rheumatoid arthritis.

Christensen AF, Lindegaard H, Hørslev-Petersen K, Hetland ML, Ejbjerg B, Stengaard-Pedersen K, Jacobsen S, Lottenburger T, Ellingsen T, Andersen LS, Hansen I, Skjødt H, Pedersen JK, Lauridsen UB, Svendsen A, Tarp U, Pødenphant J, Østergaard M, Junker P.

J Rheumatol. 2011 Aug;38(8):1563-8. doi: 10.3899/jrheum.101241. Epub 2011 May 15.

15.

Immune features of seronegative and seropositive arthritis in early synovitis studies.

Hitchon CA, El-Gabalawy HS.

Curr Opin Rheumatol. 2002 Jul;14(4):348-53. Review.

PMID:
12118166
16.

Comparable histological appearance of synovitis in seropositive and seronegative rheumatoid arthritis.

Fujinami M, Sato K, Kashiwazaki S, Aotsuka S.

Clin Exp Rheumatol. 1997 Jan-Feb;15(1):11-7.

PMID:
9093767
17.

Pathogenesis of rheumatoid arthritis.

Harris ED Jr.

Am J Med. 1986 Apr 28;80(4B):4-10.

PMID:
3486592
18.

Epigenetic changes: the missing link.

Kyburz D, Karouzakis E, Ospelt C.

Best Pract Res Clin Rheumatol. 2014 Aug;28(4):577-87. doi: 10.1016/j.berh.2014.10.014. Epub 2014 Nov 22. Review.

PMID:
25481551
19.

Detection of major histocompatibility complex/human cartilage gp-39 complexes in rheumatoid arthritis synovitis as a specific and independent histologic marker.

Baeten D, Steenbakkers PG, Rijnders AM, Boots AM, Veys EM, De Keyser F.

Arthritis Rheum. 2004 Feb;50(2):444-51.

20.

IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.

Ohtsuji M, Lin Q, Nishikawa K, Ohtsuji N, Okazaki H, Tsurui H, Amano H, Shirai T, Nishimoto N, Nishimura H, Hirose S.

Mod Rheumatol. 2015 Mar;25(2):270-7. doi: 10.3109/14397595.2014.950035. Epub 2014 Aug 27.

PMID:
25159156

Supplemental Content

Support Center